Antimalarial drug discovery – the path towards eradication
Open Access
- 17 July 2013
- journal article
- review article
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 141 (1) , 128-139
Abstract
SUMMARY: Malaria is a disease that still affects a significant proportion of the global human population. Whilst advances have been made in lowering the numbers of cases and deaths, it is clear that a strategy based solely on disease control year on year, without reducing transmission and ultimately eradicating the parasite, is unsustainable. This article highlights the current mainstay treatments alongside a selection of emerging new clinical molecules from the portfolio of Medicines for Malaria Venture (MMV) and our partners. In each case, the key highlights from each research phase are described to demonstrate how these new potential medicines were discovered. Given the increased focus of the community on eradicating the disease, the strategy for next generation combination medicines that will provide such potential is explained.Keywords
This publication has 46 references indexed in Scilit:
- Designing the next generation of medicines for malaria control and eradicationMalaria Journal, 2013
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyThe Lancet, 2012
- Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial AgentsJournal of Medicinal Chemistry, 2012
- Global Phenotypic Screening for AntimalarialsChemistry & Biology, 2012
- Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies PotentPlasmodium falciparumDihydroorotate Dehydrogenase Inhibitors with Clinical Candidate PotentialJournal of Medicinal Chemistry, 2011
- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaProceedings of the National Academy of Sciences, 2011
- Chemical genetics of Plasmodium falciparumNature, 2010
- Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in MiceJournal of Medicinal Chemistry, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- In silicoactivity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screenProceedings of the National Academy of Sciences, 2008